Yanxiao Gao, Yuewei Zhan, Yinghui Sun, Weiran Zheng, Weijie Zhang, Leiwen Fu, Zhihui Guo, Yi-Fan Lin, Yuwei Li, Lingling Zheng, Yiqiang Zhan, Zhiqiang Zhu, Junyi Duan, Guanghui Zhang, Tao Huang, Bin Su, Maohe Yu, Guohui Wu, Lin Ouyang, Jin Zhao, Guanghui Wang, Yepeng Zhou, Han-Zhu Qian, Thomas Fitzpatrick, Sten H Vermund, Huachun Zou
BACKGROUND: Observational studies suggest that voluntary medical male circumcision (VMMC) may lower HIV risk among men who have sex with men (MSM). A randomized controlled trial (RCT) is needed to confirm this. OBJECTIVE: To assess the efficacy of VMMC in preventing incident HIV infection among MSM. DESIGN: An RCT with up to 12 months of follow-up. (Chinese Clinical Trial Registry: ChiCTR2000039436). SETTING: 8 cities in China...
May 28, 2024: Annals of Internal Medicine